GMP Cytokines Market Size, Statistics Report 2022, 2027

GMP Cytokines Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Type (TNF, Interleukins, Growth Factors, and Others), and Application (Cell and Gene Therapy, Tissue- Engineered Products, and Others), and Geography

  • Report Code : TIPRE00008212
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 145
Buy Now

The GMP cytokines market was valued at US$ 84.72 million in 2019 and it is estimated to grow at a CAGR of 8.1% from 2020 to 2027.

GMP cytokines are used in cell and gene therapy for expansion and differentiation of various cell types, ex vivo cultures, and other therapeutic approaches. Moreover, these are used in various tissue engineered products for clinical applications. Additionally, extensive research is being conducted on cytokines to discover new therapeutic approaches to treat chronic conditions. The growth of the GMP cytokines market is mainly attributed to the factors such as increase in acceptance of cytokines cancer and autoimmune therapies, and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.

Lucrative Regions for GMP Cytokines Market



Lucrative Regions for GMP Cytokines Market
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Market Insights

Growing Acceptance of Cytokines for Cancer and Autoimmune Therapies

Cytokines play significant role in the regulation of innate and adaptive immunity, which enable cells of the immune system to communicate over short distances. The cytokine therapy to activate the immune system of cancer patients has been an essential parameter in the treatment of cancer and continues to be a prime contributor to present clinical cancer research. Interferon-alpha is one of the approved cytokines for the adjuvant treatment of refractory malignancies. Several research activities have proved the ability of cytokines to limit tumor cell growth by a direct anti-proliferative or pro-apoptotic activity. Moreover, some cytokines inhibit the tumor growth indirectly by stimulating the cytotoxic activity of immune cells against tumor cells. This effectiveness of cytokines therapies over cancer coupled with increasing prevalence of the disease is likely to drive the market by 2027. According to the World Health Organization, in 2019, approximately 9.6 million deaths across the globe were due to cancer.

Additionally, increasing number of investments and collaborations to develop cytokine therapies over cancer and autoimmune diseases are also expected to accelerate the market growth. For instance, in September 2020, Synthekine Inc. raised US$ 82.0 million through rounds of series funding. The company is engaged in the development of cytokine therapeutics for the treatment of cancer and autoimmune disorders.

Type -Based Insights

Based on type, the GMP cytokines market is segmented into TNF, interleukin, growth factor, and others. The growth factors segment held the largest share of the market in 2019; whereas, the TNF segment is anticipated to register the highest CAGR of 8.7% in the market during the forecast period.

GMP Cytokines Market, by Type – 2019 and 2027



GMP Cytokines Market, by Type – 2019 and 2027
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

Application-Based Insights

Based on application, the GMP cytokines market is segmented into cell and gene therapy, tissue-engineered products, and others. The cell and gene therapy segment held the largest share of the market in 2019; whereas, the tissue engineered products segment is anticipated to register the highest CAGR in the market during the forecast period.

Customize Research To Suit Your Requirement

We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.

GMP Cytokines Market: Strategic Insights

gmp-cytokines-market
Market Size Value inUS$ 84.72 Million in 2019
Market Size Value byUS$ 158.13 Million by 2027
Growth rateCAGR of 8.1% from 2020-2027
Forecast Period2020-2027
Base Year2020
Analyst Image

Akshay

Have a question?

Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.

Analyst Image  Speak to Analyst

Product launches and approvals are the commonly adopted strategies by companies to expand their global footprints and product portfolios. Collaboration is one of the major strategies adopted by the GMP cytokines market players to enlarge customer base worldwide, which also permits them to maintain their brand name globally.

GMP Cytokines Market – by Type

  • TNF
  • Interleukins
  • Growth Factors
  • Others

GMP Cytokines Market – by Application

  • Cell and Gene Therapy
  • Tissue Engineered Products
  • Others

GMP Cytokines Market – by Geography

  • North America

    • US
    • Canada
    • Mexico
  • Europe

    • France
    • Germany
    • Italy
    • UK
    • Spain
    • Rest of Europe
  • Asia Pacific (APAC)

    • China
    • India
    • South Korea
    • Japan
    • Australia
    • Rest of Asia Pacific
  • Middle East and Africa (MEA)

    • South Africa
    • Saudi Arabia
    • UAE
    • Rest of Middle East and Africa
  • South and Central America

    • Brazil
    • Argentina
    • Rest of South and Central America

Company Profiles

  • Miltenyi Biotec
  • Sino Biological Inc.
  • ABCAM
  • PeproTech Inc.
  • Akron Biotech
  • CellGenix GmbH
  • BIO-TECHNE CORPORATION
  • CREATIVE BIOARRAY
  • Proteintech Group Inc.
  • REPROCELL Inc
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Type , and Application , and Geography

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States

Frequently Asked Questions


What are GMP cytokines?

GMP cytokines are used in cell and gene therapy for expansion and differentiation of various cell types, ex vivo cultures and other therapeutic approaches. Moreover, these are also used in various tissue engineered products for clinical applications. Additionally, extensive research is being conducted on cytokines to discover new therapeutic approaches to treat chronic conditions

What are the driving factors for the GMP cytokines market across the globe?

The global GMP cytokines market growth is mainly attributed to factors such as increase in acceptance of cytokines cancer and autoimmune therapies and potential contribution in the stem cell therapy. However, high cost associated with GMP cytokines therapy is projected to deter the market growth.

Who are the major players in the GMP cytokines market?

The GMP cytokines market majorly consists of the players such as Miltenyi Biotec, Sino Biological, Inc., ABCAM, PeproTech, Inc., Akron Biotech, CellGenix GmbH, BIO-TECHNE CORPORATION, CREATIVE BIOARRAY, Proteintech Group, Inc., and REPROCELL Inc. among others.

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Global GMP Cytokines Market – By Type

1.3.2 Global GMP Cytokines Market – By Application

1.3.3 Global GMP Cytokines market – By Geography

2. GMP Cytokines Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Global GMP Cytokines – Market Landscape

4.1 Overview

4.2 PEST Analysis

4.2.1 North America – PEST Analysis

4.2.2 Europe – PEST Analysis

4.2.3 Asia Pacific – PEST Analysis

4.2.4 Middle East and Africa (MEA) – PEST Analysis

4.2.5 South and Central America (SCAM) – PEST Analysis

4.3 Expert Opinions

5. GMP Cytokines Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Growing Acceptance of Cytokines for Cancer and Autoimmune Therapies

5.1.2 Potential Contribution in Stem Cell Therapy

5.2 Market Restraints

5.2.1 High Cost Associated with GMP Cytokines Therapy

5.3 Market Opportunities

5.3.1 Extensive Pipeline of Drug Candidates for Cytokines Therapeutics

5.4 Future Trends

5.4.1 Utilization of Cytokines as Biomarkers

5.5 Impact Analysis

6. GMP Cytokines Market – Global Analysis

6.1 Global GMP Cytokines Market Revenue Forecast And Analysis

6.2 Global GMP Cytokines Market, By Geography - Forecast And Analysis

6.3 Market Positioning of Key Players

7. GMP Cytokines Market Analysis – By Type

7.1 Overview

7.2 GMP Cytokines Market Revenue Share, by Type (2019 and 2027)

7.3 TNF

7.3.1 Overview

7.3.2 TNF: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

7.4 Interleukin

7.4.1 Overview

7.4.2 Interleukin: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

7.5 Growth Factor

7.5.1 Overview

7.5.2 Growth Factor: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

7.6 Others

7.6.1 Overview

7.6.2 Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

8. GMP Cytokines Market Analysis – By Application

8.1 Overview

8.2 GMP Cytokines Market Revenue Share, by Application (2019 and 2027)

8.3 Cell/Gene Therapy

8.3.1 Overview

8.3.2 Cell/Gene Therapy: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

8.4 Tissue-Engineered Products

8.4.1 Overview

8.4.2 Tissue-Engineered Products: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

8.5 Others

8.5.1 Overview

8.5.2 Tissue-Engineered Products: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

9. GMP Cytokines Market – Geographic Analysis

9.1 North America GMP Cytokines Market Revenue And Forecasts To 2027

9.1.1 North America GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.2 North America GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.3 North America GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.1.4 North America GMP Cytokines Market Revenue and Forecasts to 2027, By Country (%)

9.1.5 US GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.5.1 US GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.5.2 US GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.5.3 US GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.1.6 Canada GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.1 Canada GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.6.2 Canada GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.6.3 Canada GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.1.7 Mexico GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.1 Mexico GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.1.7.2 Mexico GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.1.7.3 Mexico GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.2 Europe GMP Cytokines Market Revenue And Forecasts To 2027

9.2.1 Europe GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.2 Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.3 Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.2.4 Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Country (%)

9.2.5 UK GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.5.1 UK GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.5.2 UK GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.5.3 UK GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.2.6 Germany GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.1 Germany GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.6.2 Germany GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.6.3 Germany GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.2.7 France GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.1 France GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.7.2 France GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.7.3 France GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.2.8 Italy GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.1 Italy GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.8.2 Italy GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.8.3 Italy GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.2.9 Spain GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.1 Spain GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.9.2 Spain GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.9.3 Spain GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.2.10 Rest of Europe GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.10.1 Rest of Europe GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

9.2.10.2 Rest of Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

9.2.10.3 Rest of Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

9.3 Asia Pacific: GMP Cytokines Market

9.3.1 Overview

9.3.2 Asia Pacific: GMP Cytokines Market - Revenue and Forecast to 2027 (USD Million)

9.3.3 Asia Pacific: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.3.4 Asia Pacific: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

9.3.5 Asia Pacific GMP Cytokines Market Revenue and Forecasts to 2027, By Country (%)

9.3.6 China: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.3.6.1 China: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.3.6.2 China: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.3.6.3 China: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

9.3.7 Japan: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.3.7.1 Japan: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.3.7.2 Japan: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.3.7.3 Japan: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

9.3.8 India: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.3.8.1 India: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.3.8.2 India: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.3.8.3 India: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

9.3.9 South Korea: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.3.9.1 South Korea: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.3.9.2 South Korea: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.3.9.3 South Korea: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

9.3.10 Australia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.3.10.1 Australia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.3.10.2 Australia: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.3.10.3 Australia: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

9.3.11 Rest of Asia Pacific: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.3.11.1 Rest of Asia Pacific: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.3.11.2 Rest of Asia Pacific: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.3.11.3 Rest of Asia Pacific: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

9.4 Middle East & Africa: GMP Cytokines Market

9.4.1 Overview

9.4.2 Middle East & Africa: GMP Cytokines Market - Revenue and Forecast to 2027 (USD Million)

9.4.3 Middle East & Africa: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.4.4 Middle East & Africa: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

9.4.5 Middle East & Africa: GMP Cytokines Market Share by Country – 2019 & 2027, (%)

9.4.6 Saudi Arabia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.4.6.1 Saudi Arabia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.4.6.2 Saudi Arabia: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.4.6.3 Saudi Arabia: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

9.4.7 UAE: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.4.7.1 UAE: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.4.7.2 UAE: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.4.7.3 UAE: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

9.4.8 South Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

9.4.8.1 South Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.4.8.2 South Africa: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.4.8.3 South Africa: GMP Cytokines Market, by Application , 2018–2027 (USD Million)

9.4.9 Rest of Middle East and Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

9.4.9.1 Rest of Middle East and Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.4.9.2 Rest of Middle East and Africa: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.4.9.3 Rest of Middle East and Africa: GMP Cytokines Market, by Application , 2018–2027 (USD Million)

9.5 South and Central America: GMP Cytokines Market

9.5.1 Overview

9.5.2 South and Central America: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.5.3 South and Central America: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.5.4 South and Central America: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

9.5.5 South and Central America: GMP Cytokines Market, by Country, 2019 & 2027 (%)

9.5.6 Brazil: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.5.6.1 Brazil: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.5.6.2 Brazil: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.5.6.3 Brazil: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

9.5.7 Argentina: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.5.7.1 Argentina: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.5.7.2 Argentina: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.5.7.3 Argentina: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

9.5.7.4 Rest of South and Central America: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.5.7.5 Rest of South and Central America: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

9.5.7.6 Rest of South and Central America: GMP Cytokines Market, by Type, 2018–2027 (USD Million)

9.5.7.7 Rest of South and Central America: GMP Cytokines Market, by Application, 2018–2027 (USD Million)

10. Impact of COVID-19 Pandemic on Global GMP Cytokines Market

10.1 North America: Impact Assessment of COVID-19 Pandemic

10.2 Europe: Impact Assessment of COVID-19 Pandemic

10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic

10.4 Rest of the World: Impact Assessment of COVID-19 Pandemic

11. GMP Cytokines Market– Industry Landscape

11.1 Overview

11.1 Growth Strategies Done by the Companies in the Market, (%)

11.2 Organic and Inorganic Developments

11.2.1 Overview

12. Company Profiles

12.1 Miltenyi Biotec

12.1.1 Key Facts

12.1.2 Business Description

12.1.3 Products and Services

12.1.4 Financial Overview

12.1.5 SWOT Analysis

12.1.6 Key Developments

12.2 Sino Biological Inc.

12.2.1 Key Facts

12.2.2 Business Description

12.2.3 Products and Services

12.2.4 Financial Overview

12.2.5 SWOT Analysis

12.2.6 Key Developments

12.3 ABCAM

12.3.1 Key Facts

12.3.2 Business Description

12.3.3 Products and Services

12.3.4 Financial Overview

12.3.5 SWOT Analysis

12.3.6 Key Developments

12.4 PeproTech, Inc.

12.4.1 Key Facts

12.4.2 Business Description

12.4.3 Products and Services

12.4.4 Financial Overview

12.4.5 SWOT Analysis

12.4.6 Key Developments

12.5 Akron Biotech

12.5.1 Key Facts

12.5.2 Business Description

12.5.3 Products and Services

12.5.4 Financial Overview

12.5.5 SWOT Analysis

12.5.6 Key Developments

12.6 CellGenix GmbH

12.6.1 Key Facts

12.6.2 Business Description

12.6.3 Products and Services

12.6.4 Financial Overview

12.6.5 SWOT Analysis

12.6.6 Key Developments

12.7 BIO-TECHNE CORPORATION

12.7.1 Key Facts

12.7.2 Business Description

12.7.3 Products and Services

12.7.4 Financial Overview

12.7.5 SWOT Analysis

12.7.6 Key Developments

12.8 CREATIVE BIOARRAY

12.8.1 Key Facts

12.8.2 Business Description

12.8.3 Products and Services

12.8.4 Financial Overview

12.8.5 SWOT Analysis

12.8.6 Key Developments

12.9 Proteintech Group, Inc.

12.9.1 Key Facts

12.9.2 Business Description

12.9.3 Products and Services

12.9.4 Financial Overview

12.9.5 SWOT Analysis

12.9.6 Key Developments

12.10 REPROCELL, Inc.

12.10.1 Key Facts

12.10.2 Business Description

12.10.3 Products and Services

12.10.4 Financial Overview

12.10.5 SWOT Analysis

12.10.6 Key Developments

13. Appendix

13.1 About The Insight Partners

13.2 Glossary of Terms

LIST OF TABLES

Table 1. North America GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 2. North America GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 3. US GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 4. US GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 5. Canada GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 6. Canada GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 7. Mexico GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 8. Mexico GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 9. Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 10. Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 11. UK GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 12. UK GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 13. Germany GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 14. Germany GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 15. France GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 16. France GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 17. Italy GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 18. Italy GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 19. Spain GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 20. Spain GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 21. Rest of Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Type (US$ Mn)

Table 22. Rest of Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Application (US$ Mn)

Table 23. Asia Pacific GMP Cytokines Market, by Type– Revenue and Forecast to 2027 (USD Million)

Table 24. Asia Pacific GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 25. China GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 26. China GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 27. Japan GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 28. Japan GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 29. India GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 30. India GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 31. South Korea GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 32. South Korea GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 33. Australia GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 34. Australia GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 35. Rest of Asia Pacific GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 36. Rest of Asia Pacific GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 37. Middle East & Africa GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 38. Middle East & Africa GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 39. Saudi Arabia GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 40. Saudi Arabia GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 41. UAE GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 42. UAE GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 43. South Africa GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 44. South Africa GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 45. Rest of Middle East and Africa GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 46. Rest of Middle East and Africa GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 47. South and Central America GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 48. South and Central America GMP Cytokines Market, by Application – Revenue and Forecast to 2027 (USD Million)

Table 49. Brazil: GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 50. Brazil: GMP Cytokines Market, by Application, – Revenue and Forecast to 2027 (USD Million)

Table 51. Argentina: GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 52. Argentina: GMP Cytokines Market, by Application, – Revenue and Forecast to 2027 (USD Million)

Table 53. Rest of South and Central America: GMP Cytokines Market, by Type – Revenue and Forecast to 2027 (USD Million)

Table 54. Rest of South and Central America: GMP Cytokines Market, by Application, – Revenue and Forecast to 2027 (USD Million)

Table 55. Organic and Inorganic Developments Done By Companies

Table 56. Glossary of Terms, GMP Cytokines Market

LIST OF FIGURES

Figure 1. GMP Cytokines Market Segmentation

Figure 2. GMP Cytokines Market Segmentation, By Region

Figure 3. GMP Cytokines Market Overview

Figure 4. TNF Segment by Type Segment Expected to Witness Rapid Growth

Figure 5. APAC to Show Significant Growth During Forecast Period

Figure 6. GMP Cytokines Market, by Geography (US$ Million)

Figure 7. Global GMP Cytokines Market – Leading Country Markets (US$ Million)

Figure 8. Global GMP Cytokines Market, Industry Landscape

Figure 9. North America PEST Analysis

Figure 10. Europe PEST Analysis

Figure 11. Asia Pacific PEST Analysis

Figure 12. Middle East and Africa (MEA) PEST Analysis

Figure 13. South and Central America (SCAM) PEST Analysis

Figure 14. GMP Cytokines Market Impact Analysis of Drivers and Restraints

Figure 15. Global GMP Cytokines Market – Revenue Forecast And Analysis – 2019- 2027

Figure 16. Global GMP Cytokines Market – By Geography Forecast and Analysis – 2019- 2027

Figure 17. Market Positioning Of Key Players In Global GMP Cytokines Market

Figure 18. GMP Cytokines Market Revenue Share, by Type (2019 and 2027)

Figure 19. TNF: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20. Interleukin: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21. Growth Factor: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22. Others: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 23. GMP Cytokines Market Revenue Share, by Application (2019 and 2027)

Figure 24. Cell/Gene Therapy: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25. Rotating Arm: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26. Rotating Arm: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 27. North America GMP Cytokines Market Revenue Overview, by Country, 2019 (US$ Mn)

Figure 28. North America GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 29. North America GMP Cytokines Market Revenue and Forecasts to 2027, By Country (%)

Figure 30. US GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 31. Canada GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 32. Mexico GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 33. Europe GMP Cytokines Market Revenue Overview, by Country, 2019 (US$ MN)

Figure 34. Europe GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 35. Europe GMP Cytokines Market Revenue And Forecasts to 2027, By Country (%)

Figure 36. UK GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 37. Germany GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 38. France GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 39. Italy GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 40. Spain GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 41. Rest of Europe GMP Cytokines Market Revenue and Forecasts to 2027 (US$ Mn)

Figure 42. Asia Pacific: GMP Cytokines Market, by Key Country – Revenue (2019) (USD Million)

Figure 43. Asia Pacific GMP Cytokines Market Revenue and Forecast to 2027 (USD Million)

Figure 44. Asia Pacific: GMP Cytokines Market, by Country, 2019& 2027 (%)

Figure 45. China: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

Figure 46. Japan: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

Figure 47. India: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

Figure 48. South Korea: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

Figure 49. Australia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

Figure 50. Rest of Asia Pacific: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

Figure 51. Middle East & Africa: GMP Cytokines Market, by Key Country – Revenue (2019) (USD Million)

Figure 52. Middle East & Africa GMP Cytokines Market Revenue and Forecast to 2027 (USD Million)

Figure 53. Middle East & Africa: GMP Cytokines Market Share by Country – 2019 & 2027, (%)

Figure 54. Saudi Arabia: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

Figure 55. UAE: GMP Cytokines Market – Revenue and Forecast to 2027 (US$ Million)

Figure 56. South Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

Figure 57. Rest of Middle East and Africa: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

Figure 58. South and Central America: GMP Cytokines Market, by Key Country – Revenue (2019) (USD Million)

Figure 59. South and Central America GMP Cytokines Market Revenue and Forecast to 2027 (USD Million)

Figure 60. South and Central America: GMP Cytokines Market, by Country, 2019 & 2027 (%)

Figure 61. Brazil: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

Figure 62. Argentina: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

Figure 63. Rest of South and Central America: GMP Cytokines Market – Revenue and Forecast to 2027 (USD Million)

Figure 64. Impact of COVID-19 Pandemic in North America Country Markets

Figure 65. Impact of COVID-19 Pandemic in European Country Markets

Figure 66. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Figure 67. Impact Of COVID-19 Pandemic in Rest of the World Market

Figure 68. Growth Strategies Done by the Companies in the Market, (%)

The List of Companies - GMP Cytokines Market

  1. Miltenyi Biotec
  2. Sino Biological Inc.
  3. ABCAM
  4. PeproTech Inc.
  5. Akron Biotech
  6. CellGenix GmbH
  7. BIO-TECHNE CORPORATION
  8. CREATIVE BIOARRAY
  9. Proteintech Group Inc.
  10. REPROCELL Inc

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to GMP Cytokines Market